• 

  Inside Look: A Brain Health Lifestyle Trial Participant’s Story
• 

  Ones to Watch: Emerging Tech From AAIC 2025
• 

  AAIC 2025: 7 Big Takeaways from the World’s Largest Alzheimer’s Research Conference
• 

  STUDY: Lead Exposure Decades Ago Could Be Causing Memory Problems Now
• 

  Roche’s ‘Brainshuttle’ Alzheimer’s Drug Heads for Phase 3 Trials
• 

  New Guidelines: When Alzheimer’s Blood Tests Can Replace Scans and Spinal Taps
• 

  POINTER: The Lifestyle Formula That Turned Back the Brain Clock
• 

  AAIC Day 3: Dispatch from the World’s Largest Alzheimer’s Research Conference
• 

  4 Big Questions About New Alzheimer’s Anti-Amyloid Drugs, Answered
• 

  This Week: Live From the World’s Largest Alzheimer’s Research Conference
• 

  How Existing Cardiovascular Drugs Could Slow Cognitive Decline
• 

  STUDY Update: Wildfire Smoke and Dementia Risk
• 

  STUDY: Wildfire Smoke Exposure Ups Dementia Risk
• 

  Despite New Spin, Obesity and Diabetes Drug Failed Alzheimer’s Trial
• 

  The Biggest Takeaways From AAIC 2024, According to Attendees

12Next